ReviewInternational journal of hematology2021

Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine.

Xiuli Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.